Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clostridium difficile: an update.

Jonathan Gonenne1, Darrell S Pardi

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.

Comprehensive Therapy
|March 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of Microbiota Restoration Therapies for Recurrent Clostridioides difficile Infection.

The American journal of gastroenterology·2026
Same author

When Does Clostridioides difficile "Recur"? Reconcile Epidemiologic & Bedside Recurrent CDI definitions.

The Journal of infectious diseases·2026
Same author

Increasing Incidence and Prevalence of Microscopic Colitis in Sweden: A Nationwide Population-Based Cohort Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Major Adverse Cardiovascular Events and VTE in Patients with IBD Taking Anti-TNF versus JAK Inhibitors: A Multicenter Cohort Analysis.

Digestive diseases and sciences·2026
Same author

Clinical outcomes in pregnancy after ileal pouch-anal anastomosis for ulcerative colitis.

Inflammatory bowel diseases·2026
Same author

Bezlotoxumab for prevention of <i>Clostridioides difficile</i> recurrence in patients with inflammatory bowel disease: a retrospective multicenter experience.

Annals of gastroenterology·2026
Same journal

Heparin-induced thrombocytopenia and thrombosis.

Comprehensive therapy·2011
Same journal

Antiplatelet therapy in cardiovascular disease.

Comprehensive therapy·2011
Same journal

Genetics of cardiovascular disease.

Comprehensive therapy·2011
Same journal

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Comprehensive therapy·2011
Same journal

Gout and hyperuricemia.

Comprehensive therapy·2011
Same journal

Problems with computerized health records.

Comprehensive therapy·2011
See all related articles

Clostridium difficile infection (CDI) causes serious diarrhea and colitis. Recurrent CDI presents a significant clinical challenge, often requiring further treatment.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Microbiology

Background:

  • Clostridium difficile is a significant cause of infectious diarrhea.
  • C. difficile colitis can lead to severe and life-threatening medical complications.
  • Recurrent C. difficile infections pose a substantial clinical management challenge.

Purpose of the Study:

  • To review the challenges associated with recurrent Clostridium difficile infection.
  • To discuss current and emerging treatment strategies for C. difficile colitis.

Main Methods:

  • Literature review of studies on Clostridium difficile infection.
  • Analysis of clinical outcomes and treatment efficacy for recurrent CDI.

Main Results:

Related Experiment Videos

  • While many initial cases of C. difficile colitis respond to treatment, a significant proportion experience recurrence.
  • Recurrent disease necessitates advanced therapeutic approaches.
  • The severity of C. difficile infection underscores the need for effective management strategies.

Conclusions:

  • Clostridium difficile infection remains a critical public health concern.
  • Addressing recurrent C. difficile colitis is essential for improving patient outcomes.
  • Further research into novel treatments for CDI is warranted.